NS Partners’s Pfizer PFE Stock Holding History

NS Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,967	Closed	-$779K	–	83
2019 Q4	$779K	Sell	20,967 -3,701	-15%	-$132K	0.06%	83
2019 Q3	$841K	Sell	24,668 -888	-3%	-$32.3K	0.08%	77
2019 Q2	$1.05M	Sell	25,556 -8,271	-24%	-$328K	0.1%	77
2019 Q1	$1.36M	Sell	33,827 -31,833	-48%	-$1.27M	0.13%	82
2018 Q4	$2.72M	Sell	65,660 -519	-0.8%	-$21.5K	0.29%	81
2018 Q3	$2.77M	Sell	66,179 -70,979	-52%	-$2.73M	0.26%	83
2018 Q2	$4.72M	Sell	137,158 -93,919	-41%	-$3.21M	0.48%	72
2018 Q1	$7.78M	Sell	231,077 -66,614	-22%	-$2.29M	0.83%	50
2017 Q4	$10.2M	Buy	297,691 +3,311	+1%	+$113K	1.12%	37
2017 Q3	$9.97M	Buy	294,380 +832	+0.3%	+$26.7K	1.19%	35
2017 Q2	$9.36M	Sell	293,548 -90,320	-24%	-$2.85M	1.23%	34
2017 Q1	$12.5M	Buy	383,868 +419	+0.1%	+$13.2K	1.79%	11
2016 Q4	$11.8M	Sell	383,449 -4,634	-1%	-$141K	1.85%	9
2016 Q3	$12.5M	Sell	388,083 -1,032	-0.3%	-$34.5K	2.03%	7
2016 Q2	$13M	Buy	389,115 +30,079	+8%	+$960K	2.22%	4
2016 Q1	$10.1M	Sell	359,036 -53,680	-13%	-$1.53M	1.82%	13
2015 Q4	$12.6M	Sell	412,716 -39,058	-9%	-$1.23M	2.26%	5
2015 Q3	$13.5M	Sell	451,774 -8,021	-2%	-$257K	2.36%	4
2015 Q2	$14.6M	Buy	+459,795	New	+$15M	2.33%	4

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

NS Partners's PFE Position: Q1 2020 in Review

NS Partners sold out of Pfizer (PFE) in Q1 2020, closing a stake of 20,967 shares — an estimated $779K sold.

NS Partners first reported a position in PFE in Q2 2015 and held it in 19 quarters. The position peaked at $14.6M in Q2 2015. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

NS Partners reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
NS Partners sold 20,967 Pfizer shares in Q1 2020, an estimated $779K.
NS Partners first reported a position in Pfizer in Q2 2015 and held it in 19 quarters.
NS Partners's Pfizer position peaked at $14.6M in Q2 2015.
2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on NS Partners's 13F filing for Q1 2020, filed 13 May 2020.